United States Next Generation Sequencing Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     United States Next 
Generation Sequencing 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  IM A R C  G ro u p ,  t i t l e d  " U n i te d  S t a t e s  N e x t  G e n er a t i o n  
S eq u e n c in g  Ma r k e t :  In d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G ro w t h ,  O p p o r t u n i t y  a n d  
F o r e c a s t  2 0 2 4 -2 0 3 2 ,"  t h e  U n i te d  S t a te s  n e x t  g e n e ra t i o n  s e q u en c i n g  ma r k e t  s i z e  i s  
p r o j e c t ed  t o  ex h i b i t  a  g r o w t h  r a t e  ( C A GR )  o f  X X %  d u r i n g  2 0 2 4 -2 0 3 2 .
T he  U n i t e d  S t a t e s  n e x t  g e n e r a t i o n  s e q ue n c i n g  ( N G S )  ma r k e t  i s  e x p e r i e n c i n g  s i g n i f i c a n t  
Report g r o w t h ,  p r op e l l e d  b y  t he  i n c r ea s i n g  a p p l i ca t i o n  o f  N G S  t e ch n o l og i es  i n  c l i n i c a l  
d i a gn o s t i c s ,  d ru g  d i s c o v e ry ,  an d  pe r s o na l i z e d  me d i c i n e .  A d d i t i o na l l y ,  t h e  o n g o i ng  
ad v a n c e me n t s  i n  N G S  p l a t f o rm s ,  w h i c h  o f fe r  h i g he r  a c c u r a c y ,  s p e e d ,  a n d  r e d uc ed  
Highlight and se q u e n c i n g  c o s t s ,  a r e  s t i mu l a t i n g  t h e  ma r k e t  g r o w th .  
T h i s  t e c h n o l o g i c a l  e v o l u t i o n  i s  e n ab l i n g  w i d e sp r e a d  a do p t i o n  i n  v a r i ou s  f i e l d s ,  
Description i n c l u d i n g  on c o l o g y ,  g e n e t i c  d i s o r d e r s ,  a n d  i n f ec t i o u s  d i s e a se s ,  w he r e  p r ec i s e  g e n o m i c  i n s i g h t s  a r e  c r uc i a l .  M o r eo v e r ,  t h e  r i s i ng  em p h a s i s  on  p r e c i s i on  m e d i c i n e  a n d  t h e  
g r o w i n g  p r e v a l en c e  o f  ch r o n i c  d i s e a se s  h a s  h e i g h t e n e d  th e  d em a n d  f o r  N GS  t o  b e t te r  
un d e r s ta n d  d i s e a se  g e n e t i c s  a n d  c r ea t e  t a i l o r ed  t h e r a p i e s ,  w h i c h  a re  f u r t he r  
au g m e n t i n g  t he  m a r k e t  g ro w t h .
R eq u e s t  f o r  a  P D F  sa m p l e  o f  t h i s  re p o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / u n i te d - s t a t e s -n e x t - ge n e r a t i o n - s eq u e n c i ng - m a rk e t / r eq u e s ts
am p l e
Report Description
Uni ted  S ta tes  Next  Genera t i on  Sequencing  Market  T rends:
Bes ides  th is ,  t he  expand ing  research  and  deve lopmen t  ac t i v i t i es  i n  genomics ,  backed  by  subs t an t ia l  f und ing  f rom 
bo th  gove rnmen t  and p r i va te  en t i t i es  a re  boos t ing  the  Un i t ed  S ta tes  nex t  genera t ion  sequenc ing  marke t .  Moreover ,  
t he  inc reas ing  co l labo ra t i ons  be tween  academ ic  ins t i t u t ions ,  hea l t hcare  p rov iders ,  and  b io techno logy  compan ies  to  
encourage  innova t ion  and  expand  the  range o f  NGS app l i ca t i ons  a re  ac t ing  as  o the r  s ign i f i can t  f ac to rs .  
Add i t i ona l l y ,  t he  inco rpora t ion  o f  mach ine  learn ing  and  a r t i f i c ia l  i n te l l i gence  w i th  NGS da ta  ana lys i s  t o  enhance the  
e f f i c iency  o f  genomic  research  and  c l in i ca l  d iagnos t i cs  i s  c rea t ing  a  pos i t i ve  ou t l ook  fo r  t he  marke t .  Fur thermore ,  t he  
inc reas ing  adop t ion  o f  NGS in  p rena ta l  t es t i ng ,  cance r  sc reen ing ,  and  ra re  d isease  d iagnos is  a re  a l so  con t r ibu t ing  to  
the  marke t  g rowt h .  Bes ides  t h is ,  t he  ongo ing  t echno log i ca l  advancement s  and t he  i n t eg ra t i on  o f  NGS in  r ou t ine  
c l i n i ca l  p rac t i ce  a re  expec t ed  t o  d r i ve  the  Un i t ed  S t a t es  nex t  genera t ion  sequenc ing  marke t  in  t he  coming  yea rs .
Vi ew Repor t  TOC,  F igures  and Tab l es :  
h t tps : / /www. imarcgroup . com/un i ted -s ta tes-next -genera t i on -sequenci ng-market
Sequencing Type Insights:
• Whole Genome Sequencing
• Targeted Resequencing
• Whole Exome Sequencing
• RNA Sequencing
• CHIP Sequencing
Report • De Novo Sequencing
• Methyl  Sequencing
Segmentation • Others
Product Type Insights:
• Instruments
• Reagents and Consumables
• Software and Services
Technology Insights:
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time Sequencing
• Nanopore Sequencing
• Others
Report 
Segmentation Application Insights:
• Biomarker and Cancer
• Drug Discovery and Personal ized Medicine
• Genetic Screening
• Diagnost ics
• Agriculture and Animal Research
• Others
End User Insights:
• Academic Insti tutes and Research Centers
• Hospitals and Cl inics
• Pharmaceutical  and Biotechnology Companies
Report • Others
Segmentation
Regional Insights:
• Northeast
• Midwest
• South
• West
How has the United States next generation sequencing 
market performed so far and how will it perform in the 
coming years?
What has been the impact of COVID-19 on the United 
States next generation sequencing market?
Key What is the breakup of the United States next generation sequencing market on the basis of 
sequencing type?
Questions 
What is the breakup of the United States next 
Answered in generation sequencing market on the basis of product type?
the Report
What is the breakup of the United States next 
generation sequencing market on the basis of 
technology?
What is the breakup of the United States next 
generation sequencing market on the basis of 
application?
What is the breakup of the United States next 
generation sequencing market on the basis of end 
user?
What are the various stages in the value chain of the 
United States next generation sequencing market?
What are the key driving factors and challenges in the 
United States next generation sequencing?
Key What is the structure of the United States next generation sequencing market and who are the key 
players?
Questions 
What is the degree of competition in the United States 
next generation sequencing market?
Answered in 
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    U n i t e d  S t a t e s  N e x t  G e n e r a t i o n  S e q u e n c i n g  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    U n i t e d  S t a t e s  N e x t  G e n e r a t i o n  S e q u e n c i n g  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
6    U n i t e d  S t a t e s  N e x t  G e n e r a t i o n  S e q u e n c i n g  M a r k e t  -  B r e a k u p  b y  S e q u e n c i n g  
T y p e
    6 . 1     W h o l e  G e n o m e  S e q u e n c i n g
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    6 . 2     T a r g e t e d  R e s e q u e n c i n g
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
       
    6 . 3     W h o l e  E x o m e  S e q u e n c i n g
        6 . 3 . 1  O v e r v i e w
        6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    6 . 4     R N A  S e q u e n c i n g
        6 . 4 . 1  O v e r v i e w
        6 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 4 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    6 . 5     C H I P  S e q u e n c i n g
        6 . 5 . 1  O v e r v i e w
        6 . 5 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
Table of         6 . 5 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )    6 . 6     D e  N o v o  S e q u e n c i n g
        6 . 6 . 1  O v e r v i e w
Contents         6 . 6 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )        6 . 6 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    6 . 7     M e t h y l  S e q u e n c i n g
        6 . 7 . 1  O v e r v i e w
        6 . 7 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 7 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    6 . 8     O t h e r s
        6 . 8 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 8 . 2  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
7    U n i t e d  S t a t e s  N e x t  G e n e r a t i o n  S e q u e n c i n g  M a r k e t  -  B r e a k u p  
b y  P r o d u c t  T y p e
    7 . 1     I n s t r u m e n t s
        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /u n i t ed - s ta t es -nex t -g ene ra t i on - s
equenc i ng -m a rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]